CJC-1295 (No DAC) + Ipamorelin Blend – 20mg

CJC-1295 (No DAC) + Ipamorelin Blend – 20mg
Targeted Growth Hormone Secretagogue Complex — 10mg / 10mg

Biovexa's blend pairs Mod GRF (1-29) / CJC-1295 (No DAC) with Ipamorelin for the study of pulsatile growth hormone signalling. It is investigated for its ability to mimic natural biological release patterns without elevating cortisol or prolactin in preclinical models.

Key research focus: Pituitary signalling, endogenous GH release, lean mass preservation.

Form: Lyophilized powder — ≥99% purity (HPLC)
Content: 20mg per 3ml vial (10mg + 10mg)
Storage: Store at 2–8 °C, protected from light
Origin: Made in USA

For research use only. Not for human or animal consumption. Not a drug, food, supplement or cosmetic, and not intended to diagnose, treat, cure or prevent any disease. Qualified researchers only. See our Research Use Policy.